Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    19713265 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep Apnea
Condition: Obstructive Sleep Apnea
Interventions: Drug: Sugammadex;   Drug: Neostigmine
2 Completed Comparison of Org 25969 With Neostigmine as Reversal Agents for Rocuronium or Vecuronium at Reappearance of T2 (19.4.301)(P05960)
Condition: Anesthesia, General
Interventions: Drug: Sugammadex;   Drug: neostigmine

Indicates status has not been verified in more than two years